Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma
- 1 August 1989
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 28 (8) , 791-797
- https://doi.org/10.1016/0028-3908(89)90169-x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Source and physiological significance of plasma 3,4-dihydroxyphenylglycol and 3-methoxy-4-hydroxyphenylglycolJournal of the Autonomic Nervous System, 1988
- Effects of debrisoquin on the excretion of catecholamine and octopamine metabolites in the rat and guinea pigBiochemical Pharmacology, 1985
- The Clinical Syndrome of Striatal Dopamine DeficiencyNew England Journal of Medicine, 1985
- Effects of intraventricular injections of 6-hydroxydopamine on amine metabolites in rat brain and urineBiochemical Pharmacology, 1985
- Plasma Homovanillic Acid Concentration and the Severity of Schizophrenic IllnessScience, 1985
- Reduced peripheral presynaptic adrenoceptor sensitivity following chronic antidepressant treatment in ratsBritish Journal of Pharmacology, 1985
- Neurochemical and behavioral effects of systematic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the ratEuropean Journal of Pharmacology, 1984
- Further studies on the synthesis of A-form monoamine oxidase.The Japanese Journal of Pharmacology, 1981
- 3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: Possible indicators of central dopaminergic activityEuropean Journal of Pharmacology, 1979
- Monoamine oxidase inhibition in the adrenergic neuron by bretylium, debrisoquin, and other adrenergic neuronal blocking agentsBiochemical Pharmacology, 1967